Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 2,issue 2  (07-2002)

Period of time： 2002年2期

Publisher： Bentham Science Publishers

Founded in： 2001

Total resources： 18

E-ISSN： 1875-5917|2|2

ISSN： 1568-0088

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 2,issue 2

Menu

Recombinant Adenovirus-mediated Cytotoxic Gene Therapy and Lymphoproliferative Disorders: Analysis Based on Pharmacodynamics

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 2,issue 2 , Vol. 2, Iss. 2, 2002-07 , pp. 109-118

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Targeting the AMP-Activated Protein Kinase for the Treatment of Type 2 Diabetes

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 2,issue 2 , Vol. 2, Iss. 2, 2002-07 , pp. 119-127

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Inhibitors of Post-Translational Modifications of G-Proteins as Probes to Study the Pancreatic #946; Cell Function: Potential Therapeutic Implications

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 2,issue 2 , Vol. 2, Iss. 2, 2002-07 , pp. 129-139

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Novel Targets for Therapy in Paediatric Oncology

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 2,issue 2 , Vol. 2, Iss. 2, 2002-07 , pp. 141-150

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Therapeutic Potential of the Mammalian Pyruvate Dehydrogenase Kinases in the Prevention of Hyperglycaemia

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 2,issue 2 , Vol. 2, Iss. 2, 2002-07 , pp. 151-165

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Molecular Basis of Hyperparathyroidism and Potential Targets for Drug Development

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 2,issue 2 , Vol. 2, Iss. 2, 2002-07 , pp. 167-179

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Apoptotic Cell Death in Renal Injury: The Rationale for Intervention

Current Drug Targets - Immune, Endocrine & Metabolic Disorders,volume 2,issue 2 , Vol. 2, Iss. 2, 2002-07 , pp. 181-192

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 7 item(s)